Retrospective cohort study of health service use for cardiovascular disease among adults with and without a record of injury hospital admission

被引:0
作者
Randall, Sean M. [1 ]
Wood, Fiona M. [2 ,3 ,4 ]
Fear, Mark W. [2 ]
Boyd, James [5 ]
Rea, Suzanne [2 ,3 ,4 ]
Duke, Janine M. [2 ]
机构
[1] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia
[2] Univ Western Australia, Fac Hlth & Med Sci, Burn Injury Res Unit, Perth, WA, Australia
[3] Burns Serv Western Australia, Fiona Stanley Hosp, Perth, WA, Australia
[4] Burns Serv Western Australia, Perth Childrens Hosp, Perth, WA, Australia
[5] La Trobe Univ, Dept Publ Hlth, Melbourne, Vic, Australia
来源
BMJ OPEN | 2020年 / 10卷 / 11期
关键词
epidemiology; trauma management; cardiology; BETA-BLOCKADE; STRESS-RESPONSE; BURN TRAUMA; IMPACTS;
D O I
10.1136/bmjopen-2020-039104
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To quantify postinjury cardiovascular-related health service use experienced by mid to older aged adults hospitalised for injury, compared with uninjured adults. Additionally, to explore the effect of beta-blocker medications on postinjury cardiovascular hospitalisations among injury patients, given the potential cardioprotective effects of beta blockers. Design A retrospective cohort study using linked administrative and survey data. Participants Records of 35 026 injured and 60 823 uninjured matched adults aged over 45 from New South Wales, Australia, who completed the 45 and up survey. Primary and secondary outcome measures Admission rates and cumulative lengths of stay for cardiovascular hospitalisations, and prescription rates for cardiovascular medications. Negative binomial and Cox proportional hazards regression modelling were used to generate incident rate ratios (IRRs) and HR. Results Compared with the uninjured, those with injury had a 19% higher adjusted rate of postinjury cardiovascular admissions (IRR 1.19, 95% CI 1.14 to 1.25), spent 40% longer in hospital for ardiovascular disease (IRR 1.40, 95% CI 1.26 to 1.57) and had slightly higher cardiovascular prescription rates (IRR 1.04, 95% CI 1.02 to 1.06), during study follow-up. Those in the injury cohort that used beta blockers both prior to and after injury (continuous) appeared to have reduced need for post-injury cardiovascular hospitalisation (IRR 1.09, 95% CI 1.17 to 1.42) compared with those commencing on beta blockers after injury (after 30 days: IRR 1.69, 95% CI 1.37 to 2.08). Conclusions Apparent increased postinjury hospitalisation rates and prolonged length of stay related to cardiovascular disease suggest that injury patients may require clinical support for an extended period after injury. Additionally, injury patients who were on continuous beta blocker treatment appeared to have lower need for post-injury cardiovascular hospitalisations. However, the data do not allow us to draw clear conclusions and further clinical research is required.
引用
收藏
页数:12
相关论文
共 48 条
  • [41] Canadian Veteran chronic disease prevalence and health services use in the five years following release: a matched retrospective cohort study using routinely collected data
    Mahar, Alyson L.
    St Cyr, Kate
    Enns, Jennifer E.
    Aiken, Alice B.
    Whitehead, Marlo
    Cramm, Heidi
    Kurdyak, Paul
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [42] Risk of cardiovascular disease associated with repeated proteinuria across annual kidney function screening among the middle-aged and older general population in Japan: a retrospective cohort study
    Ohnishi, Tsuyoshi
    Mori, Yuichiro
    Fukuma, Shingo
    BMJ OPEN, 2023, 13 (07):
  • [43] Inequities in Rural and Urban Health Care Utilization Among Individuals Diagnosed With Inflammatory Bowel Disease: A Retrospective Population-Based Cohort Study From Saskatchewan, Canada
    Pena-Sanchez, Juan Nicolas
    Osei, Jessica Amankwah
    Rohatinsky, Noelle
    Lu, Xinya
    Risling, Tracie
    Boyd, Ian
    Wicks, Kendall
    Wicks, Mike
    Quintin, Carol-Lynne
    Dickson, Alyssa
    Fowler, Sharyle A.
    JOURNAL OF THE CANADIAN ASSOCIATION OF GASTROENTEROLOGY, 2022, 6 (02) : 55 - 63
  • [44] Risk of hospitalization with neurodegenerative disease after moderate-to-severe traumatic brain injury in the working- age population: A retrospective cohort study using the Finnish national health registries
    Raj, Rahul
    Kaprio, Jaakko
    Korja, Miikka
    Mikkonen, Era D.
    Jousilahti, Pekka
    Siironen, Jari
    PLOS MEDICINE, 2017, 14 (07):
  • [45] Nationally Representative Rates of Incident Prescription Opioid Use Among United States Adults and Selected Subpopulations: Longitudinal Cohort Study From the National Health Interview Survey, 2019 to 2020
    D'Souza, Ryan S.
    Nahin, Richard L.
    JOURNAL OF PAIN, 2024, 25 (11)
  • [46] Association between Triglyceride-Glucose Index and risk of all-cause and cardiovascular mortality in adults with prior cardiovascular disease: a cohort study using data from the US National Health and Nutrition Examination Survey, 2007-2018
    Hu, Ben
    Wang, Yuhui
    Wang, Yan
    Feng, Jun
    Fan, Yinguang
    Hou, Linlin
    BMJ OPEN, 2024, 14 (07):
  • [47] Association of red cell distribution width (RDW) and the RDW to platelet count ratio with cardiovascular disease among US adults: a cross-sectional study based on the National Health and Nutrition Examination Survey 1999-2020
    Ainiwaer, Aikeliyaer
    Kadier, Kaisaierjiang
    Abulizi, Anniwaer
    Hou, Wen Qing
    Rehemuding, Rena
    Maimaiti, Halimulati
    Yakufu, Mubalake
    Ma, Xiang
    Ma, Yi-Tong
    BMJ OPEN, 2023, 13 (03):
  • [48] The patterns of antifungal use and risk factors associated with mortality in patients with invasive candidiasis and aspergillosis infections among patients who were received infectious disease specialist consultation prior to and during the COVID-19 pandemic in a resource-limited setting: A retrospective cohort study
    Vaivoothpinyo, Supavit
    Jantarathaneewat, Kittiya
    Weber, David J.
    Camins, Bernard C.
    Apisarnthanarak, Piyaporn
    Rutjanawech, Sasinuch
    Apisarnthanarak, Anucha
    AMERICAN JOURNAL OF INFECTION CONTROL, 2025, 53 (03) : 314 - 319